Cargando…
Steroids: A Therapeutic Option for COVID-19 Pneumonia Patients With ESRD?
Autores principales: | Delafosse, Marion, Saint-Jaques, Camille, Petit-Hoang, Camille, François, Hélène, Peltier, Julie, Nicolet, Laurence, Verney, Charles, Viguier, Martin, Letavernier, Emmanuel, Dahan, Karine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298510/ https://www.ncbi.nlm.nih.gov/pubmed/32775845 http://dx.doi.org/10.1016/j.ekir.2020.05.031 |
Ejemplares similares
-
Serum Albumin Still of Interest to Predict Outcomes in Membranous Nephropathy in the Era of Phospholipase A2 Receptor
por: Delafosse, Marion, et al.
Publicado: (2020) -
Lower Mortality in Living Kidney Donors With ESRD Versus Matched Nondonors With ESRD
por: Muzaale, Abimereki D.
Publicado: (2018) -
Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia
por: Abe, Tatsuki, et al.
Publicado: (2020) -
Acute Purulent Pericarditis Caused by Klebsiella Pneumonia in a Patient ESRD on Hemodialysis
por: Manjunath, Sachin, et al.
Publicado: (2023) -
Iron status in ESRD patients
por: Wiwanitkit, V.
Publicado: (2011)